A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease (Q81308465)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 March 2005

Language	Label	Description	Also known as
English	A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease	scientific article published on 01 March 2005

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15665852%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15665852%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Mustafa Benekli

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15665852%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Hahn T

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15665852%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Wong C

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15665852%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Moysich KB

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15665852%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Hyland A

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15665852%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Michalek AM

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15665852%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Alam A

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15665852%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Baer MR

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15665852%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Bambach B

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15665852%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Czuczman MS

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15665852%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Wetzler M

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15665852%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Becker JL

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15665852%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

McCarthy PL

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15665852%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 March 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15665852%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15665852%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

35

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15665852%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15665852%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

557-566

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15665852%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704789

0 references

Approach to Hodgkin's lymphoma in the new millennium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long-term follow-up in 128 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy and autologous stem cell rescue for patients with Hodgkin's disease in first relapse after chemotherapy: results from the EBMT. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study. Société Francaise de Greffe de Moelle.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Conventional salvage chemotherapy vs. high-dose therapy with autografting for recurrent or refractory Hodgkin's disease patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic marrow transplantation for refractory Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of blood and marrow transplantation for Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic or autologous stem cell transplantation (SCT) for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma: a single-centre experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of prognostic models in patients with advanced Hodgkin disease. Promising results from integration of the best three systems.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Hodgkin's disease prognosis: a directly predictive equation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for survival in stage IIIB and IV Hodgkin's disease: a multivariate analysis comparing two specialist treatment centres

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

A numerical prognostic index for clinical use in identification of poor-risk patients with Hodgkin's disease at diagnosis. Scotland and Newcastle Lymphoma Group (SNLG) Therapy Working Party

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for disease progression in advanced Hodgkin's disease: an analysis of patients aged under 60 years showing no progression in the first 6 months after starting primary chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis of patients with advanced Hodgkin's disease: evaluation of four prognostic models using 344 patients included in the Group d'Etudes des Lymphomes de l'Adulte Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory Hodgkin disease: a Southwest Oncology Group phase II trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Thiotepa-associated cardiomyopathy during blood or marrow transplantation: association with the female sex and cardiac risk factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Regimen-related toxicity in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy and autologous stem cell transplantation in relapsed and refractory Hodgkin's disease: outcome based on a prognostic model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of Nonmyeloablative Allogeneic Stem-Cell Transplantation After Failure of Autologous Transplantation in Patients With Lymphoproliferative Malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

BEAM allogeneic transplantation for patients with Hodgkin's disease who relapse after autologous transplantation is safe and effective

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704789

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81308465&oldid=1465421820"